Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (37)
Alan F. Schatzberg & Sanjay J. Mathew. (2023) The why, when, where, how, and so what of so-called rapidly acting antidepressants. Neuropsychopharmacology 49:1, pages 189-196.
Crossref
Crossref
Jamie L. Scholl, Rajeshwari R. Solanki, Michael J. Watt, Kenneth J. Renner & Gina L. Forster. (2023) Chronic administration of glucocorticoid receptor ligands increases anxiety-like behavior and selectively increase serotonin transporters in the ventral hippocampus. Brain Research 1800, pages 148189.
Crossref
Crossref
Peipei Yan, Yi Deng, Xi Su, Hesheng Kong, Yichi Zhang, Wenqiang Li & Eryan Kong. 2023. Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders. Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders
3
43
.
Mirko Manchia & Alan Schatzberg. 2020. Tasman’s Psychiatry. Tasman’s Psychiatry
1
33
.
Amanda Larosa & Tak Pan Wong. (2022) The hippocampus in stress susceptibility and resilience: Reviewing molecular and functional markers. Progress in Neuro-Psychopharmacology and Biological Psychiatry 119, pages 110601.
Crossref
Crossref
Poliane da Silva Calixto, Reinaldo Nóbrega de Almeida, Mirian G.S. Stiebbe Salvadori, Mayara dos Santos Maia, José Maria Barbosa Filho, Marcus Tullius Scotti & Luciana Scotti. (2021) In Silico Study Examining New Phenylpropanoids Targets with Antidepressant Activity. Current Drug Targets 22:5, pages 539-554.
Crossref
Crossref
Miquel Bioque, Alexandre González-Rodríguez, Clemente Garcia-Rizo, Jesús Cobo, José Antonio Monreal, Judith Usall, Virginia Soria & Javier Labad. (2021) Targeting the microbiome-gut-brain axis for improving cognition in schizophrenia and major mood disorders: A narrative review. Progress in Neuro-Psychopharmacology and Biological Psychiatry 105, pages 110130.
Crossref
Crossref
玺 卢. (2021) Progress in Neurophysiological Mechanisms of Depression. Advances in Psychology 11:07, pages 1759-1767.
Crossref
Crossref
Jennifer B. DwyerAwais AftabRajiv RadhakrishnanAlik WidgeCarolyn I. RodriguezLinda L. CarpenterCharles B. NemeroffWilliam M. McDonaldNed H. Kalin. (2020) Hormonal Treatments for Major Depressive Disorder: State of the Art. American Journal of Psychiatry 177:8, pages 686-705.
Crossref
Crossref
Sarah Gregory, David Hill, Ben Grey, William Ketelbey, Tamara Miller, Graciela Muniz-Terrera & Craig W. Ritchie. (2020) 11β-hydroxysteroid dehydrogenase type 1 inhibitor use in human disease-a systematic review and narrative synthesis. Metabolism 108, pages 154246.
Crossref
Crossref
Jenni Sireeni, Nina Bakker, Gayathri Jaikumar, Daisy Obdam, Hans Slabbekoorn, Christian Tudorache & Marcel Schaaf. (2020) Profound effects of glucocorticoid resistance on anxiety-related behavior in zebrafish adults but not in larvae. General and Comparative Endocrinology 292, pages 113461.
Crossref
Crossref
Giulia Lombardo, Daniela Enache, Laura Gianotti, Alan F. Schatzberg, Allan H. Young, Carmine M. Pariante & Valeria Mondelli. (2019) Baseline cortisol and the efficacy of antiglucocorticoid treatment in mood disorders: A meta-analysis. Psychoneuroendocrinology 110, pages 104420.
Crossref
Crossref
Katja Wingenfeld & Christian Otte. (2019) Mineralocorticoid receptor function and cognition in health and disease. Psychoneuroendocrinology 105, pages 25-35.
Crossref
Crossref
José Antonio Monreal, Fabrice Duval, Marie-Claude Mokrani, Said Fattah & Diego Palao. (2019) Differences in multihormonal responses to the dopamine agonist apomorphine between unipolar and bipolar depressed patients. Journal of Psychiatric Research 112, pages 18-22.
Crossref
Crossref
Jin-Bo Yu, Zhen-Xiong Zhao, Ran Peng, Li-Bin Pan, Jie Fu, Shu-Rong Ma, Pei Han, Lin Cong, Zheng-Wei Zhang, Li-Xin Sun, Jian-Dong Jiang & Yan Wang. (2019) Gut Microbiota-Based Pharmacokinetics and the Antidepressant Mechanism of Paeoniflorin. Frontiers in Pharmacology 10.
Crossref
Crossref
Mingsan Miao, Mengfan Peng, Hongbao Chen & Baosong Liu. (2019) Effects of Baihe Dihuang powder on chronic stress depression rat models. Saudi Journal of Biological Sciences 26:3, pages 582-588.
Crossref
Crossref
Thea Marianne Grützner, Anuradha Sharma, Lena Listunova, Marina Bartolovic, Matthias Weisbrod & Daniela Roesch-Ely. (2019) Neurocognitive performance in patients with depression compared to healthy controls: Association of clinical variables and remission state. Psychiatry Research 271, pages 343-350.
Crossref
Crossref
Xi-Dan Zhou, Dong-Dong Shi & Zhang-Jin Zhang. (2019) Antidepressant and anxiolytic effects of the proprietary Chinese medicine Shexiang Baoxin pill in mice with chronic unpredictable mild stress. Journal of Food and Drug Analysis 27:1, pages 221-230.
Crossref
Crossref
Jeffrey M. Miller, Francesca Zanderigo, Priya D. Purushothaman, Christine DeLorenzo, Harry Rubin-Falcone, R. Todd Ogden, John Keilp, Maria A. Oquendo, Nabeel Nabulsi, Yiyun H. Huang, Ramin V. Parsey, Richard E. Carson & J. John Mann. (2018) Kappa opioid receptor binding in major depression: A pilot study. Synapse 72:9, pages e22042.
Crossref
Crossref
Virginia Soria, Alexandre González-Rodríguez, Elena Huerta-Ramos, Judith Usall, Jesús Cobo, Miquel Bioque, Juan David Barbero, Clemente García-Rizo, Meritxell Tost, José Antonio Monreal & Javier Labad. (2018) Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis. Psychoneuroendocrinology 93, pages 8-19.
Crossref
Crossref
Thaddeus S. Block, Harvey Kushner, Ned Kalin, Craig Nelson, Joseph Belanoff & Alan Schatzberg. (2018) Combined Analysis of Mifepristone for Psychotic Depression: Plasma Levels Associated With Clinical Response. Biological Psychiatry 84:1, pages 46-54.
Crossref
Crossref
Madhuri R. Tolahunase, Rajesh Sagar, Muneeb Faiq & Rima Dada. (2018) Yoga- and meditation-based lifestyle intervention increases neuroplasticity and reduces severity of major depressive disorder: A randomized controlled trial. Restorative Neurology and Neuroscience 36:3, pages 423-442.
Crossref
Crossref
Carolin Leistner & Andreas Menke. (2018) How to measure glucocorticoid receptor’s sensitivity in patients with stress-related psychiatric disorders. Psychoneuroendocrinology 91, pages 235-260.
Crossref
Crossref
Xiangting Li, Ting Wu, Zhonghai Yu, Tingting Li, Jingsi Zhang, Zhennian Zhang, Min Cai, Wen Zhang, Jun Xiang & Dingfang Cai. (2018) Apocynum venetum leaf extract reverses depressive-like behaviors in chronically stressed rats by inhibiting oxidative stress and apoptosis. Biomedicine & Pharmacotherapy 100, pages 394-406.
Crossref
Crossref
Carina Rampp, Andreas Eichelkraut, Johanna Best, Darina Czamara, Monika Rex-Haffner, Manfred Uhr, Elisabeth B. Binder & Andreas Menke. (2018) Sex-related differential response to dexamethasone in endocrine and immune measures in depressed in-patients and healthy controls. Journal of Psychiatric Research 98, pages 107-115.
Crossref
Crossref
Thaddeus BlockGeorgios PetridesHarvey KushnerNed KalinJoseph BelanoffAlan Schatzberg. (2017) Mifepristone Plasma Level and Glucocorticoid Receptor Antagonism Associated With Response in Patients With Psychotic Depression. Journal of Clinical Psychopharmacology 37:5, pages 505-511.
Crossref
Crossref
Katja Wingenfeld, Linn K. Kuehl, Anita Boeker, Katharina Schultebraucks, Kristin Ritter, Julian Hellmann-Regen, Christian Otte & Carsten Spitzer. (2017) Stress reactivity and its effects on subsequent food intake in depressed and healthy women with and without adverse childhood experiences. Psychoneuroendocrinology 80, pages 122-130.
Crossref
Crossref
Qiu-Qin Han, Liu Yang, Hui-Jie Huang, Ya-Lin Wang, Rui Yu, Jing Wang, Adam Pilot, Gen-Cheng Wu, Qiong Liu & Jin Yu. (2017) Differential GR Expression and Translocation in the Hippocampus Mediates Susceptibility vs. Resilience to Chronic Social Defeat Stress. Frontiers in Neuroscience 11.
Crossref
Crossref
Susanne Fischer, Rebecca Strawbridge, Andres Herane Vives & Anthony J. Cleare. (2018) Cortisol as a predictor of psychological therapy response in depressive disorders: Systematic review and meta-analysis. British Journal of Psychiatry 210:2, pages 105-109.
Crossref
Crossref
Marita Pruessner, Alexis E. Cullen, Monica Aas & Elaine F. Walker. (2017) The neural diathesis-stress model of schizophrenia revisited: An update on recent findings considering illness stage and neurobiological and methodological complexities. Neuroscience & Biobehavioral Reviews 73, pages 191-218.
Crossref
Crossref
Andreas G. Moraitis, Thaddeus Block, Dat Nguyen & Joseph K. Belanoff. (2017) The role of glucocorticoid receptors in metabolic syndrome and psychiatric illness. The Journal of Steroid Biochemistry and Molecular Biology 165, pages 114-120.
Crossref
Crossref
Rainer Rupprecht. 2017. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
279
290
.
Christian Otte, Stefan M. Gold, Brenda W. Penninx, Carmine M. Pariante, Amit Etkin, Maurizio Fava, David C. Mohr & Alan F. Schatzberg. (2016) Major depressive disorder. Nature Reviews Disease Primers 2:1.
Crossref
Crossref
Alan F. Schatzberg. (2015) Development of New Psychopharmacological Agents for Depression and Anxiety. Psychiatric Clinics of North America 38:3, pages 379-393.
Crossref
Crossref
Jack D. Barchas & Benjamin D. Brody. (2015) Perspectives on depression-past, present, futurea. Annals of the New York Academy of Sciences 1345:1, pages 1-15.
Crossref
Crossref
Alan F. Schatzberg. (2015) Issues encountered in recent attempts to develop novel antidepressant agents. Annals of the New York Academy of Sciences 1345:1, pages 67-73.
Crossref
Crossref
Rainer Rupprecht. 2016. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1
12
.